Background & Summary
====================

CAGE (Cap Analysis Gene Expression^[@b1]^) is the method of choice for studying gene regulation through quantitative analysis of transcription start sites (TSS, sequence ontology term 0000315)^[@b2]^. By sequencing the 5′ end of cDNA-converted capped RNAs, CAGE enables the identification of core promoter regions and 5′ end transcriptional activity. Large scale application of CAGE by the FANTOM consortium to nearly 2,000 human RNA sources including primary cells, whole-tissue extracts and cell lines^[@b3],[@b4]^ identified nearly 200,000 core promoter regions active within the human genome^[@b5]^.

Although CAGE enables the location of TSS at a single nucleotide resolution, the determination of their connection to downstream known gene structures or to independent novel RNAs is limited to positional computational inference and low-throughput gene-by-gene experimental validations. Half (101,893/201,802) of the FANTOM5's active core promoter regions did not co-localise within a reasonable distance with 5′ termini of annotated gene models. To experimentally associate these orphan core promoter regions to transcriptional units, we employed *CAGEscan*^[@b6]^, an approach in which paired-end sequencing of the 5′ end of cDNA-converted capped RNAs with their cognate randomly priming sites enables the unequivocal association of individual TSS to transcripts exons. In a previous project, focused on analysing the translatome of Purkinje neurons in rat^[@b7]^, the CAGEscan approach annotated 43 % of the core promoters active in rat's Purkinje neurons that we detected but had no by direct overlap with Ensembl transcripts.

Here, we selected 56 RNA sources which upon FANTOM5 CAGE profiling revealed the greatest levels of transcriptome diversity and prepared individual CAGEscan libraries, with 6 of these 56 RNA sources prepared in duplicate (see [Table 1](#t1){ref-type="table"}). Using the FANTOM5 core promoter atlas as seed, we clustered the CAGEscan paired-end reads in a collection of 112,315 models called *CAGEscan clusters*, by collating all the pairs whose alignment started in the same FANTOM5 CAGE peak. To de-orphanise FANTOM5 promoters, we intersected the CAGEscan clusters with GENCODE 18 gene models. Of the 85 % that intersected, 33,632 clusters had no annotation in FANTOM5, thus revealing novel and alternative promoters to known genes. We made these data available along with the FANTOM5 CAGE atlas data, as well as ready for manual inspection and analysis via the ZENBU genome browser <http://fantom.gsc.riken.jp/zenbu/gLyphs/#config=ZkJi4RdBAFhnsudxePrZxD> (see [Fig. 1](#f1){ref-type="fig"}).

Methods
=======

All human samples used in the project were either exempted material (available in public collections or commercially available), or provided under informed consent. All non-exempt material is covered under RIKEN Yokohama Ethics applications (H17--34 and H21-14). The CAGEscan libraries were prepared as described earlier^[@b8]^. In brief, 500 ng of RNA were reverse-transcribed in presence of random primers and template-switching oligonucleotides, amplified by PCR and sequenced paired-end (2×36 nt) on Illumina GAIIx sequencers, one sample per lane. The barcode sequence GCTATA, present in every sample, acted as the spacer that we introduced in ref. [@b9] to decrease the amount of strand-invasion artefacts. The paired-end sequences were then processed with the MOIRAI workflow system^[@b10]^, with a template implementing the workflow OP-WORKFLOW-CAGEscan-FANTOM5-v1.0, described below and in [Fig. 2](#f2){ref-type="fig"}.

For each pair, the first (CAGE) and second (CAGEscan) reads in FASTQ format were demultiplexed. The first 9 bases of the CAGE reads were trimmed as they contain the sample barcode and the template-switching linker. CAGEscan paired-end reads that did not contain the exact barcode and linker sequences were discarded. The first 6 bases of the CAGEscan reads were trimmed, because they originate from the random primers and not the cDNAs, and therefore are prone to errors caused by mismatches during the hybridisation to the RNAs, that are well tolerated by the reverse-transcriptase^[@b11]^.

The CAGE and CAGEscan reads were then filtered independently with the TagDust program version 1.13 (ref. [@b12]), using the sequences of empty constructs and primers as artefact library. They were then compared to reference sequences of ribosomal genes (GenBank: U13369.1) using the rRNAdust program version 1.03. Reads whose mates were discarded by these two filters were then removed.

FASTQ formatted cleaned paired-end reads were then aligned on the human genome version hg19 with BWA version 0.7.15 (ref. [@b13]) using standard parameters, except that the maximum insert length (−a) was set to 2 Mbp to allow pairs to map on different exons, and that insert size detection was disabled (−A). Extra header records (for SQ: AS and for RG: CN, ID, LB, PU, SM, and PL) were added to ease processing and tracking. The resulting BWA SAM formatted alignments were then converted to BAM format, and unmapped as well as non-properly paired CAGE reads were discarded (flag 0×42). The resulting 'CAGEscan pairs' provide individual experimental information on the association of a single-nucleotide-resolution TSS with the body of a gene product.

The CAGEscan pairs were then converted to BED12 format using the program pairedBamToBed12 version 1.2, in which the score field is the sum of the mapping qualities of each read of the pair. They were then assembled into CAGEscan clusters using the CAGEscan-Clustering script version 1.2 and the Phase 1+2 FANTOM5 DPI CAGE peaks as seeds. The CAGEscan-Clustering script also takes advantage of the BED12 format, reporting the number of CAGEscan paired-end reads used to assemble each cluster via the score field and the name and position of the seeding CAGE peak via the name, thickStart and thickEnd fields respectively. Finally, the CAGEscan clusters from all libraries were then combined into a single global assembly of 'meta-clusters' using the same program and output in BED12 files where the score indicates the number of libraries contributing data to each meta-cluster.

Code availability
-----------------

The MOIRAI workflow template used to process the libraries is available as a supplemental XML file (Data Citation 1). MOIRAI enabled the design of a complete data processing pipeline based on the following softwares: FASTX-Toolkit (<http://hannonlab.cshl.edu/fastx_toolkit/>), TagDust 1.13 (ref. [@b12]), rRNAdust 1.03 (<http://fantom.gsc.riken.jp/5/sstar/Protocols:rRNAdust>) (note that for new projects, we recommend TagDust 2 instead of TagDust 1 and rRNAdust), BWA 0.7.15-r1140^[@b13]^, SAMtools 0.1.19-44428cd^[@b14]^, pairedBAMtoBED12 1.2 (<https://github.com/Population-Transcriptomics/pairedBamToBed12>, Data Citation 2), CAGEscan-Clustering.pl 1.2 (<https://github.com/nicolas-bertin/CAGEscan-Clustering>, Data Citation 3) and promexinstats.sh for the annotation (see Data Citation 1). The software above and standard Unix tools are sufficient to re-implement the pipeline in a different workflow system.

Data Records
============

Each CAGEscan library is described with a Sample and Data Relationship Format (SDRF) record, together with the rest of the FANTOM5 data^[@b15]^. For each library, raw sequences in FASTQ format, alignment data in BAM format (including unmapped reads), CAGEscan pairs in BED12 format, CAGEscan clusters in BED12 format and alignment statistics in plain text tabulation-delimited triples (subject, predicate, object), are available in the FANTOM5 data repository (<http://fantom.gsc.riken.jp/5/datafiles/phase2.3/basic/>). The raw sequences have also been deposited to DDBJ Sequence Read Archive (Data Citation 4).

Technical Validation
====================

We derived individual library alignment statistics from the MOIRAI data processing pipeline (see [Table 1](#t1){ref-type="table"} and [Figs 2](#f2){ref-type="fig"} and [3a](#f3){ref-type="fig"}). The statistics count the number of reads discarded at key steps of the processing. 'Unextracted' are pairs where the linker was not found, 'Artefacts' are pairs that matched the artefact library, or had a low complexity, 'rDNA' are pairs that matched the reference rDNA locus (including rRNAs and their spacer regions), 'Non-aligned' are pairs where one or both mates were not aligned to the genome, and 'Non-proper' are pairs where the mates were not aligned in head-to-head orientation within 2 Mbp. 'Duplicates' are the pairs removed during the deduplication step. That is, when there are *n* pairs with identical coordinates, 1 is kept and *n*−1 are discarded as 'Duplicates'. These statistics show that the amount of PCR duplicates was not larger than the number of CAGEscan pairs, suggesting that the libraries prepared in this study have not been fully exhausted by sequencing.

The library alignment statistics, as well as statistics describing the distribution of CAGEscan TSSs on GENCODE 19 annotations ([Fig. 3b](#f3){ref-type="fig"}), also suggest that the biological nature of the samples (cancer cell lines, primary cells, tissue samples and brain tissue) strongly influenced the performance of the CAGEscan protocol used in this study. Albeit displaying the best performance in terms of alignment (largest fraction of CAGEscan pairs), brain tissue derived samples had the lowest rate of known promoters overlapping start sites, hinting at a much greater diversity of alternative promoters usage in human brain. However, since, in this study, all brain tissue derived samples were taken from a single donor, this observation may result from technical batch effect rather than being a general feature of the nature of human brain transcriptome.

To assess the reproducibility and consistency of our libraries, we computed a Jaccard similarity index between the lists of FANTOM5 CAGE peaks detected in each possible pair of libraries. For each sample analysed in duplicate, the library with the highest similarity was the replicate ([Fig. 4](#f4){ref-type="fig"}). Hierarchical clustering of the libraries tended to group the samples by type rather than by batch. Accordingly, library NCig10014, typed as 'Tissue' together with other samples obtained from Ambion's FirstChoice Human Total RNA Survey Panel, and containing its brain RNA pool, clustered with the donor-derived 'Brain samples'. Together with the similarity of replicates, this provides confidence that the data reflects the biological contents of the libraries and not batch effects.

Usage Notes
===========

We have seeded the CAGEscan clustering with FANTOM5 CAGE-defined core promoter regions, however alternative seeding strategies could be envisioned. The 5′ ends of the CAGEscan pairs themselves could be clustered by peak calling and used as a seed, which is the default mode of operation of the pairedBamToBed12 tool. Foregoing the discovery of alternative promoters, CAGEscan clusters could also be seeded using promoter regions defined by GENCODE models. To discover potential enhancer-associated non-coding RNAs, region corresponding to FANTOM5 enhancers^[@b16]^ could also be used.

We used a simple alignment strategy that did not take splicing into account. Thus, pairs overlapping splice junctions could not be mapped and CAGEscan clusters lack coverage at the beginning and end of each exon, but this only mildly impacts the main purpose of the method. In addition, since the CAGEscan pairs are anchored at the 5′ end of the transcripts, splice junctions occurring close to the TSS may render some whole loci unmappable. Indeed, transcripts databases such as GENCODE reveal splice junctions very near to the TSS. Trimming the CAGE reads to 20 nt rescued some loci, but other loci were lost due to the decrease of alignment stringency (data not shown).

One of the most striking differences between the HeliScopeCAGE-based FANTOM5 CAGE data and the nanoCAGE-based FANTOM5 CAGEscan data is a larger amount of start sites in the gene body, far from the promoter. This can be explained by the lower stringency of the nanoCAGE protocol, which uses template-switching for capturing 5′ ends from limiting amounts of samples^[@b6]^, where the HeliScopeCAGE protocol, that uses CAP Trapper^[@b17]^, would not be possible. Readers curious about the position of the random priming site, indicated by the end position of the CAGEscan pairs, will notice that their distribution is very far from random. Control experiments performed using different batches of random primers ordered by different makers confirmed that the quality of the oligonucleotides was not in question (data not shown). In the latest version of the nanoCAGE protocol^[@b18]^, this problem was solved by the fragmentation of the cDNAs by the 'tagmentation' method. Altogether, we recommend to use our latest protocol for making new libraries.

In this study, the CAGEscan libraries were prepared using the nanoCAGE method, but the CAGEscan workflow, which can use any paired-end sequencing of CAGE libraries were the 3′ sequencing read is at a random position in the cDNA, can be applied to other publicly available dataset, for instance made with the RAMPAGE method^[@b19]^.
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![ZENBU view of CAGEscan data.\
CAGEscan clusters revealing new promoters for the SH3BGRL2 gene. Features on the plus and minus strand are displayed in green and purple respectively. Promoter regions of interest are highlighted with ellipses in track D. (**a**) Genomic coordinates. (**b**) FANTOM5 CAGE signal as a quantitative histogram. (**c**) CAGEscan CAGE signal. (**d**) CAGEscan meta-clusters, combining pairs for all libraries. The name of the seed CAGE peak is indicated on the left of each cluster. (**e**) NCBI Gene bodies. (**f**) GENCODE 19 annotations. (**g**) GenBank mRNA sequences. (**h**) EST sequences supporting the CAGEscan clusters.](sdata2017147-f1){#f1}

![FANTOM5 CAGEscan processing workflow.\
Processing pipeline. The diagram made of boxes connected by black arrows displays the MOIRAI workflow completed for one (NCig10013) of the 62 CAGEscan libraries. The coloured text and arrows overlayed on the diagram represents the points where the main alignment statistics are calculated to summarise the number of read pairs passing all the filters (CAGEscan pairs) or discarded at each step of the processing pipeline (Unextracted, rDNA, Artefacts, Non-aligned, Non-proper, Duplicates).](sdata2017147-f2){#f2}

![Alignment and annotation statistics. Quality control statistics.\
(**a**) Fraction of pairs passing all filters (CAGEscan pairs) or discarded at key steps of the processing pipeline (see [Fig. 2](#f2){ref-type="fig"}). The central block of stack bars represents each library individually. The left block aggregates them by sequencing batch, named by the sequencing run identifier. The right block aggregates the libraries by sample type. Each sample type is represented by one colour, that is also used to colour the library identifiers and the sequence identifiers in the other blocks. Batches comprising multiple types are indicated by multiple colours. (**b**) Fraction of pairs starting in a Promoter, Exon, or Other (non-promoter, non-exon) region.](sdata2017147-f3){#f3}

![Similarity between libraries.\
Heatmap of the Jaccard similarity indexes computed between each pair of libraries. Sample type and batches are indicated by a colour code near library names, and pairs of replicates are indicated by an asterisk superimposed to the square displaying their similarity index.](sdata2017147-f4){#f4}

###### Summary of the libraries prepared.

               **Source Name**  **Description**                                                               **Total**    **Unextracted**   **Artefacts**   **rDNA**     **Non aligned**   **Non proper**   **Duplicates**   **Promoter**   **Exon**    **Non annotated**
  ----------- ----------------- ----------------------------------------------------------------------------- ------------ ----------------- --------------- ------------ ----------------- ---------------- ---------------- -------------- ----------- -------------------
  NCig10013      10002-101A5    SABiosciences XpressRef Human Universal Total RNA, pool1                      12,980,474   865,232           53,578          8,620,490    303,381           336,125          914,464          352,035        557,012     978,157
  NCig10014      10012-101C3    brain, adult, pool1                                                           10,041,908   789,460           56,053          3,579,617    156,712           499,657          1,967,826        479,841        1,007,678   1,505,064
  NCig10015      10016-101C7    heart, adult, pool1                                                           17,071,911   657,065           67,493          12,680,315   189,587           360,818          1,791,722        341,589        679,820     303,502
  NCig10016      10026-101D8    testis, adult, pool1                                                          12,778,881   735,402           56,663          8,828,467    229,250           357,108          761,921          321,059        575,393     913,618
  NCig10017      10030-101E3    retina, adult, pool1                                                          7,438,898    983,120           49,209          2,016,040    91,931            396,226          1,395,594        341,442        574,800     1,590,536
  NCig10018      11210-116A4    Smooth Muscle Cells---Aortic, donor0                                          16,069,580   636,805           76,008          14,079,255   126,255           163,413          505,347          152,188        219,216     111,093
  NCig10019      12176-128I7    Whole blood (ribopure), donor090325, donation1                                11,721,271   745,633           59,630          5,626,776    168,819           557,490          1,749,239        502,772        701,914     1,608,998
  NCig10020      10019-101D1    lung, adult, pool1                                                            13,194,146   853,743           90,406          8,943,567    141,998           347,985          819,745          309,787        599,126     1,087,789
  NCig10021      10022-101D4    prostate, adult, pool1                                                        11,134,114   746,116           64,413          6,095,769    167,516           486,536          1,152,553        366,192        716,651     1,338,368
  NCig10022      10025-101D7    spleen, adult, pool1                                                          8,339,981    852,309           62,976          3,130,575    143,638           431,102          1,038,248        402,237        785,577     1,493,319
  NCig10023      10150-102I6    medial frontal gyrus, adult, donor10252                                       4,512,027    960,285           25,800          467,916      81,388            389,764          534,385          224,651        506,845     1,320,993
  NCig10024      10151-102I7    amygdala, adult, donor10252                                                   6,314,079    858,652           33,503          1,112,179    112,044           450,492          801,134          321,988        702,445     1,921,642
  NCig10025      10153-102I9    hippocampus, adult, donor10252                                                5,068,313    892,716           32,233          861,081      80,184            360,888          643,485          241,503        530,452     1,425,771
  NCig10026      10154-103A1    thalamus, adult, donor10252                                                   8,151,958    817,751           35,872          2,262,386    95,945            505,911          1,296,220        377,511        716,479     2,043,883
  NCig10027      10155-103A2    medulla oblongata, adult, donor10252                                          9,999,787    1,397,247         78,367          2,366,286    132,873           610,522          1,541,331        446,644        906,737     2,519,780
  NCig10028      10157-103A4    parietal lobe, adult, donor10252                                              9,456,143    936,084           71,291          1,471,269    153,886           694,447          1,387,954        463,355        1,096,767   3,181,090
  NCig10029      10158-103A5    substantia nigra, adult, donor10252                                           7,656,663    1,078,146         59,251          2,360,698    85,562            425,712          1,188,939        344,322        602,764     1,511,269
  NCig10030      10159-103A6    spinal cord, adult, donor10252                                                9,651,183    888,981           79,200          2,801,018    116,324           594,991          1,353,570        442,320        903,764     2,471,015
  NCig10031      10160-103A7    pineal gland, adult, donor10252                                               7,577,434    1,011,960         65,055          1,343,792    103,948           545,004          944,389          348,323        744,959     2,470,004
  NCig10032      10161-103A8    globus pallidus, adult, donor10252                                            11,489,499   821,077           80,387          4,015,936    130,251           673,588          1,632,249        469,685        916,587     2,749,739
  NCig10033      10162-103A9    pituitary gland, adult, donor10252                                            8,630,256    970,964           49,755          1,932,932    124,341           563,707          1,591,606        455,105        847,858     2,093,988
  NCig10034      10163-103B1    occipital cortex, adult, donor10252                                           9,407,509    905,254           44,694          1,193,623    136,650           708,731          1,223,230        432,869        1,030,595   3,731,863
  NCig10035      10164-103B2    caudate nucleus, adult, donor10252                                            6,816,957    1,102,408         38,186          869,711      109,813           476,042          1,310,808        346,046        754,780     1,809,163
  NCig10036      10165-103B3    locus coeruleus, adult, donor10252                                            6,753,026    1,045,453         49,711          1,251,961    97,962            454,490          1,173,365        330,395        729,525     1,620,164
  NCig10037      10166-103B4    cerebellum, adult, donor10252                                                 6,025,035    1,095,992         54,415          368,370      62,650            519,173          650,125          254,418        492,016     2,527,876
  NCig10038      11207-116A1    Endothelial Cells---Aortic, donor0                                            15,261,564   718,897           98,322          12,128,937   142,908           291,064          820,844          298,247        455,971     306,374
  NCig10039      11222-116B7    Fibroblast---Gingival, donor4 (GFH2)                                          5,865,574    885,111           167,833         2,081,881    108,043           284,519          1,080,129        346,774        547,431     363,853
  NCig10040      11224-116B9    CD14+ Monocytes, donor1                                                       11,232,175   651,017           101,461         4,297,440    152,438           540,035          1,268,085        510,000        645,877     3,065,822
  NCig10041      11229-116C5    CD14+ monocyte derived endothelial progenitor cells, donor1                   10,775,321   1,032,309         242,145         3,950,479    190,791           539,087          1,666,613        561,795        835,546     1,756,556
  NCig10042      11245-116E3    Fibroblast---Aortic Adventitial, donor1                                       9,543,436    735,498           828,670         3,376,827    198,604           517,858          2,135,913        655,705        710,317     384,044
  NCig10043      11246-116E4    Intestinal epithelial cells (polarized), donor1                               6,681,741    919,980           392,820         1,056,095    120,525           433,407          2,003,503        513,395        536,761     705,255
  NCig10044      11247-116E5    Mesothelial Cells, donor1                                                     7,150,721    870,202           443,481         1,547,197    127,726           418,103          2,291,855        516,801        516,012     419,344
  NCig10045      11248-116E6    Anulus Pulposus Cell, donor1                                                  9,329,478    673,123           467,283         4,733,836    191,255           418,230          1,674,689        474,236        571,373     125,453
  NCig10046      11249-116E7    Pancreatic stromal cells, donor1                                              6,917,860    895,678           266,841         1,598,919    129,096           447,633          1,839,323        563,482        606,168     570,720
  NCig10047      11256-116F5    Small Airway Epithelial Cells, donor1                                         8,934,394    762,215           197,286         3,113,793    175,723           506,591          2,330,196        629,638        801,987     416,965
  NCig10048      11273-116H4    Mammary Epithelial Cell, donor1                                               10,019,381   890,533           198,834         4,561,811    208,742           497,865          2,025,351        497,139        721,321     417,785
  NCig10049      11278-116H9    Placental Epithelial Cells, donor1                                            11,212,007   523,668           434,079         7,019,440    196,493           358,154          1,908,353        304,347        296,384     171,089
  NCig10050      11282-116I4    Skeletal muscle cells differentiated into Myotubes---multinucleated, donor1   8,911,706    825,574           278,816         3,852,864    174,167           447,392          2,002,086        521,214        534,883     274,710
  NCig10051      11468-119C1    Preadipocyte---omental, donor1                                                5,109,588    863,018           244,070         1,743,473    94,850            257,299          790,493          304,494        524,536     287,355
  NCig10052      11487-119E2    Mast cell---stimulated, donor1                                                4,388,468    1,047,459         53,428          390,687      86,272            312,008          1,219,897        244,001        294,922     739,794
  NCig10053      10411-106B6    renal cell carcinoma cell line:OS-RC-2                                        6,905,711    774,316           209,703         2,297,666    117,997           421,779          1,058,325        387,862        580,214     1,057,849
  NCig10054      10412-106B7    malignant trichilemmal cyst cell line:DJM-1                                   9,858,285    728,347           139,130         3,031,554    164,712           630,434          2,045,672        648,552        895,267     1,574,617
  NCig10055      10414-106B9    maxillary sinus tumor cell line:HSQ-89                                        9,125,063    857,517           135,611         2,250,778    123,989           579,817          1,951,209        498,578        697,019     2,030,545
  NCig10056      10431-106D8    epidermoid carcinoma cell line:Ca Ski                                         5,074,986    1,071,422         146,593         982,637      87,543            343,508          859,004          378,966        452,570     752,743
  NCig10057      10436-106E4    signet ring carcinoma cell line:Kato III                                      8,693,941    840,579           145,687         3,244,444    137,763           512,628          1,657,263        503,623        614,540     1,037,414
  NCig10058      10442-106F1    schwannoma cell line:HS-PSS                                                   7,714,618    941,029           176,159         1,799,562    134,668           519,866          1,659,980        589,180        733,263     1,160,911
  NCig10059      10444-106F3    glioblastoma cell line:A172                                                   8,266,061    861,701           175,094         2,804,921    186,736           495,954          1,209,931        520,670        712,755     1,298,299
  NCig10060      10454-106G4    chronic myelogenous leukemia cell line:K562                                   4,756,581    1,045,797         109,272         645,627      70,593            363,272          675,740          342,295        400,380     1,103,605
  NCig10061      10464-106H5    acute lymphoblastic leukemia (T-ALL) cell line:Jurkat                         9,344,079    869,111           131,089         2,562,674    178,216           687,478          1,748,129        774,916        819,425     1,573,041
  NCig10062      10508-107D4    neuroblastoma cell line:CHP-134, tech_rep1                                    4,622,691    962,974           148,947         278,618      57,421            405,741          662,738          258,098        391,938     1,456,216
  NCig10063      10552-107I3    cervical cancer cell line:D98-AH2, tech_rep1                                  4,307,425    1,005,845         156,179         421,514      70,319            310,350          1,186,016        271,445        368,888     516,869
  NCig10064      10558-107I9    osteosarcoma cell line:HS-Os-1, tech_rep1                                     4,374,077    983,856           182,894         548,737      80,879            357,116          711,651          286,493        395,130     827,321
  NCig10065      10410-106B5    extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS, tech_rep1             3,965,350    928,677           138,036         393,526      64,950            343,707          582,912          220,600        400,189     892,753
  NCig10066      10441-106E9    synovial sarcoma cell line:HS-SY-II, tech_rep1                                4,039,831    844,408           197,018         574,814      57,821            348,974          523,331          235,006        375,904     882,555
  NCig10067      10474-106I6    myeloma cell line:PCM6, tech-rep1                                             4,582,185    810,459           186,856         755,594      71,301            358,371          807,453          278,280        416,507     897,364
  NCig10068      10424-106D1    splenic lymphoma with villous lymphocytes cell line:SLVL                      4,458,999    852,283           163,002         455,663      80,461            376,376          969,585          280,831        377,707     903,091
  NCig10126      10508-107D4    neuroblastoma cell line:CHP-134, tech_rep2                                    5,259,146    995,795           48,625          550,450      63,938            396,327          701,319          298,112        438,554     1,766,026
  NCig10127      10552-107I3    cervical cancer cell line:D98-AH2, tech_rep2                                  4,097,389    1,015,542         60,740          646,950      64,609            304,041          930,823          243,837        338,193     492,654
  NCig10128      10558-107I9    osteosarcoma cell line:HS-Os-1, tech_rep2                                     4,681,628    968,282           75,235          865,891      76,828            336,463          737,523          296,891        409,283     915,232
  NCig10129      10410-106B5    extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS, tech_rep2             3,118,570    822,752           40,614          436,600      112,425           377,956          276,992          152,854        276,872     621,505
  NCig10130      10441-106E9    synovial sarcoma cell line:HS-SY-II, tech_rep2                                3,232,761    726,773           64,905          633,633      81,424            473,478          240,861          160,678        250,046     600,963
  NCig10131      10474-106I6    myeloma cell line:PCM6, tech-rep2                                             3,985,344    720,124           60,988          898,043      78,483            322,369          566,406          231,781        346,042     761,108
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